Literature DB >> 22056141

Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.

Laura Magri1, Marco Cambiaghi, Manuela Cominelli, Clara Alfaro-Cervello, Marco Cursi, Mauro Pala, Alessandro Bulfone, Jose Manuel Garcìa-Verdugo, Letizia Leocani, Fabio Minicucci, Pietro Luigi Poliani, Rossella Galli.   

Abstract

Tuberous Sclerosis Complex (TSC) is a multisystem genetic disorder characterized by hamartomatous neurological lesions that exhibit abnormal cell proliferation and differentiation. Hyperactivation of mTOR pathway by mutations in either the Tsc1 or Tsc2 gene underlies TSC pathogenesis, but involvement of specific neural cell populations in the formation of TSC-associated neurological lesions remains unclear. We deleted Tsc1 in Emx1-expressing embryonic telencephalic neural stem cells (NSCs) and found that mutant mice faithfully recapitulated TSC neuropathological lesions, such as cortical lamination defects and subependymal nodules (SENs). These alterations were caused by enhanced generation of SVZ neural progeny, followed by their premature differentiation and impaired maturation during both embryonic and postnatal development. Notably, mTORC1-dependent Akt inhibition and STAT3 activation were involved in the reduced self-renewal and earlier neuronal and astroglial differentiation of mutant NSCs. Thus, finely tuned mTOR activation in embryonic NSCs may be critical to prevent development of TSC-associated brain lesions. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056141     DOI: 10.1016/j.stem.2011.09.008

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  108 in total

Review 1.  Stem cell guidance through the mechanistic target of rapamycin.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

2.  Distinct germline progenitor subsets defined through Tsc2-mTORC1 signaling.

Authors:  Robin M Hobbs; Hue M La; Juho-Antti Mäkelä; Toshiyuki Kobayashi; Tetsuo Noda; Pier Paolo Pandolfi
Journal:  EMBO Rep       Date:  2015-02-19       Impact factor: 8.807

3.  Loss of postnatal quiescence of neural stem cells through mTOR activation upon genetic removal of cysteine string protein-α.

Authors:  Jose L Nieto-González; Leonardo Gómez-Sánchez; Fabiola Mavillard; Pedro Linares-Clemente; María C Rivero; Marina Valenzuela-Villatoro; José L Muñoz-Bravo; Ricardo Pardal; Rafael Fernández-Chacón
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-29       Impact factor: 11.205

Review 4.  Brain response to calorie restriction.

Authors:  Salvatore Fusco; Giovambattista Pani
Journal:  Cell Mol Life Sci       Date:  2012-12-27       Impact factor: 9.261

5.  Prevention of premature death and seizures in a Depdc5 mouse epilepsy model through inhibition of mTORC1.

Authors:  Lindsay K Klofas; Brittany P Short; Chengwen Zhou; Robert P Carson
Journal:  Hum Mol Genet       Date:  2020-05-28       Impact factor: 6.150

Review 6.  Novel directions for diabetes mellitus drug discovery.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang
Journal:  Expert Opin Drug Discov       Date:  2012-10-24       Impact factor: 6.098

Review 7.  Genetic animal models of malformations of cortical development and epilepsy.

Authors:  Michael Wong; Steven N Roper
Journal:  J Neurosci Methods       Date:  2015-04-21       Impact factor: 2.390

8.  Neural progenitors derived from Tuberous Sclerosis Complex patients exhibit attenuated PI3K/AKT signaling and delayed neuronal differentiation.

Authors:  Avery J Zucco; Valentina Dal Pozzo; Alina Afinogenova; Ronald P Hart; Orrin Devinsky; Gabriella D'Arcangelo
Journal:  Mol Cell Neurosci       Date:  2018-08-23       Impact factor: 4.314

9.  Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients.

Authors:  William E Wu; Ivan I Kirov; Assaf Tal; James S Babb; Sarah Milla; Joseph Oved; Howard L Weiner; Orrin Devinsky; Oded Gonen
Journal:  Epilepsy Behav       Date:  2013-03-22       Impact factor: 2.937

Review 10.  A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.

Authors:  David M Feliciano; Tiffany V Lin; Nathaniel W Hartman; Christopher M Bartley; Cathryn Kubera; Lawrence Hsieh; Carlos Lafourcade; Rachel A O'Keefe; Angelique Bordey
Journal:  Int J Dev Neurosci       Date:  2013-02-26       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.